See more : FLYHT Aerospace Solutions Ltd. (FLY.V) Income Statement Analysis – Financial Results
Complete financial analysis of Akili, Inc. (AKLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Akili, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- centrotherm international AG (CTNK.F) Income Statement Analysis – Financial Results
- Eastern Bankshares, Inc. (EBC) Income Statement Analysis – Financial Results
- Tele Columbus AG (TC1.DE) Income Statement Analysis – Financial Results
- Graf Global Corp. (GRAF) Income Statement Analysis – Financial Results
- Malayan Flour Mills Berhad (3662.KL) Income Statement Analysis – Financial Results
Akili, Inc. (AKLI)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.akiliinteractive.com
About Akili, Inc.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.68M | 323.00K | 538.00K | 3.94M | 19.99M |
| Cost of Revenue | 819.00K | 441.00K | 355.00K | 416.00K | 1.34M |
| Gross Profit | 859.00K | -118.00K | 183.00K | 3.52M | 18.64M |
| Gross Profit Ratio | 51.19% | -36.53% | 34.01% | 89.44% | 93.29% |
| Research & Development | 19.93M | 28.86M | 18.23M | 15.42M | 21.27M |
| General & Administrative | 38.84M | 53.84M | 29.78M | 13.54M | 18.88M |
| Selling & Marketing | 6.58M | 7.86M | 12.89M | 0.00 | 0.00 |
| SG&A | 45.42M | 61.70M | 42.67M | 13.54M | 18.88M |
| Other Expenses | 4.04M | 82.73M | 17.00K | 124.00K | 1.03M |
| Operating Expenses | 65.34M | 90.56M | 60.90M | 28.96M | 40.14M |
| Cost & Expenses | 66.16M | 91.00M | 61.26M | 29.38M | 41.48M |
| Interest Income | 0.00 | 1.48M | 8.32K | 333.00K | 157.00K |
| Interest Expense | 2.36M | 1.48M | 465.00K | 333.00K | 157.00K |
| Depreciation & Amortization | 302.00K | 308.00K | 296.00K | 424.00K | 1.29M |
| EBITDA | -60.14M | -88.89M | -60.44M | -25.01M | -20.21M |
| EBITDA Ratio | -3,584.21% | -28,073.37% | -11,231.04% | -634.98% | -101.14% |
| Operating Income | -64.49M | -90.68M | -60.72M | -25.44M | -21.50M |
| Operating Income Ratio | -3,842.97% | -28,073.37% | -11,286.06% | -645.75% | -107.57% |
| Total Other Income/Expenses | 5.05M | 82.73M | -629.00K | -209.00K | 877.00K |
| Income Before Tax | -59.49M | -7.95M | -61.35M | -25.65M | -20.62M |
| Income Before Tax Ratio | -3,545.47% | -2,459.75% | -11,402.97% | -651.05% | -103.18% |
| Income Tax Expense | 53.00K | 19.00K | 482.00K | 1.00K | 13.00K |
| Net Income | -59.49M | -7.96M | -61.83M | -25.65M | -20.63M |
| Net Income Ratio | -3,545.47% | -2,465.63% | -11,492.57% | -651.08% | -103.24% |
| EPS | -0.76 | -0.27 | -1.94 | -0.33 | -0.27 |
| EPS Diluted | -0.76 | -0.27 | -1.94 | -0.33 | -0.27 |
| Weighted Avg Shares Out | 78.20M | 29.88M | 31.89M | 77.86M | 77.86M |
| Weighted Avg Shares Out (Dil) | 78.20M | 29.88M | 31.89M | 77.86M | 77.86M |
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTCⓇ (AKL-T01) as an over-the-counter treatment for adults with attention-deficit/hyperactivity disorder (ADHD). Delivered through an engaging video game experience, EndeavorOTC...
AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLI
NEW ORLEANS , June 14, 2024 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger and Expiring Tender Offer - AKLI and CALT
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, SGE on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLI
NEW ORLEANS, LA / ACCESSWIRE / June 5, 2024 / Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, WIRE on Behalf of Shareholders
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. – AKLI
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are...
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. - AKLI
NEW YORK , June 4, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered...
AKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akili, Inc. (NASDAQ: AKLI) to Virtual Therapeutics for $0.4340 per share of common stock in cash is fair to Akili shareholders. Halper Sadeh encourages...
Source: https://incomestatements.info
Category: Stock Reports